Rankings
▼
Calendar
VRCA Q4 2022 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$56M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$68,000
Gross Profit
-$3M
-4444.1% margin
Operating Income
-$6M
-9133.8% margin
Net Income
-$6M
-8723.5% margin
EPS (Diluted)
$-1.44
QoQ Revenue Growth
-99.2%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$45M
Total Liabilities
$5M
Stockholders' Equity
$40M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$68,000
$0
—
Gross Profit
-$3M
-$200,000
-1411.0%
Operating Income
-$6M
-$8M
+26.7%
Net Income
-$6M
-$10M
+37.8%
← FY 2022
All Quarters
Q1 2023 →